April 17, 2019 Partnership for the development of therapeutic antibodies Bayer Animal Health and adivo sign global collaboration agreement Bayer to strengthen its portfolio of products for companion animals ...Read more
April 16, 2019 Bayer and Fair Planet renew commitment to improve access to seeds in EthiopiaFive-year renewal aims to improve food and nutrition security, provide economic opportunities for smallholder farmers in Ethiopia ...Read more
April 12, 2019 Dr. Monika Lessl to lead both the Bayer Science and the Bayer Cares FoundationsRead more
April 8, 2019 Bayer welcomes science-based discussion with regulators, researchers and the public:More than 100 Bayer-owned glyphosate safety study reports accessible as Monsanto integration continuesRead more
April 2, 2019 Leaps by Bayer and Khloris join forces to develop induced pluripotent stem cells (iPSCs) as breakthrough anti-cancer vaccinesSeed investment of Leaps by Bayer paves an exclusive leadership position for next generation oncology business / Research study from Stanford University suggests that vaccination with iPSCs may cure and prevent the development of many types of cancer ...Read more
SPECIALIZED PRESS April 2, 2019 Thought leaders emphasize cattle health and well-being for the sustainable development of the beef industryMore than 220 cattle professionals engage over key topics of parasite control, bovine respiratory disease, reproduction, digital innovation and well-being at the 2nd Bayer International Beef Symposium ...Read more
March 29, 2019 CVBD World Forum discuss a changing world in vector-borne DiseasesThe 14th CVBD™ (Companion Vector-Borne Diseases) World Forum welcomed parasitologists, veterinary clinicians and epidemiology experts ...Read more
March 27, 2019 Bayer statement on jury’s decision in phase two of California glyphosate trialRead more
March 27, 2019 Not intended for U.S. and UK Media - American Association for Cancer Research (AACR) 110th Annual Meeting:Bayer to showcase latest oncology research at AACR 2019 underscoring its commitment to advancing the future of cancer careData presentation from ongoing Phase I study with BAY 2731954 (formerly LOXO-195), an oral and selective investigational next-generation TRK inhibitor ...Read more
SPECIALIZED PRESS March 26, 2019 Bayer receives positive opinion from European Medicines Agency for Baycox® Iron injection for pigletsBayer’s novel, patented toltrazuril plus gleptoferron injectable combination is a step closer to European authorization ...Read more
